Avania Welcomes New Chief Operating Officer
Avania, a prominent figure in the MedTech industry, is thrilled to announce the appointment of Charlene Dark as its new Chief Operating Officer (COO). Her extensive experience in operational strategy is set to enhance the company's commitment to clinical development and advisory services.
Charlene Dark: A Leader in Operational Strategy
Charlene Dark brings over three decades of invaluable expertise to Avania. Throughout her career, she has been known for her innovative, forward-thinking approaches. Before joining Avania, Dark served as the executive vice president of global clinical analytics at Clinipace, later known as Caidya. During her tenure, she was instrumental in driving commercial growth while enhancing operational efficiency within the company's global analytics solutions.
Focus on Innovation and Long-Term Success
Expressing her enthusiasm for her new role, Dark stated, “I am honored to step into the role of Avania’s COO and work alongside such a talented and dedicated team. As we navigate the evolving needs of the MedTech industry, my focus will be on fostering innovation and aligning our operations to meet immediate challenges while positioning Avania for sustainable long-term success.”
Dark's commitment to implementing actionable strategies and achieving measurable outcomes will be pivotal in shaping the company's future direction while reinforcing its reputation in MedTech advisory and development.
Supporting Clients Through All Stages
The president and CEO of Avania, Jason Monteleone, highlighted Dark's critical role in the company's growth. According to him, “Charlene’s data-driven decision-making, grounded in extensive clinical development experience, will be an asset to our clients and team. She plays a critical role in our next phase of growth supporting a flexible operating model that meets the diverse needs of our sponsors.”
About Avania
Avania is a leading global MedTech advisory and clinical development partner specializing in medical devices, diagnostics, and digital health. The company offers comprehensive clinical research outsourcing, market access, reimbursement, regulatory, and product development advisory services. Avania envisions being the trusted partner in the journey of medical technology, from innovation through commercialization and improving patient health and well-being.
Frequently Asked Questions
Who is the new COO of Avania?
Charlene Dark has been appointed as the new COO of Avania, bringing over 30 years of experience in clinical development.
What experience does Charlene Dark bring to Avania?
Charlene Dark has extensive experience in operational strategy and previously served as the executive vice president of global clinical analytics at Clinipace.
What are the primary services offered by Avania?
Avania focuses on medical devices and diagnostics, offering full-service clinical research outsourcing, regulatory, market access, and product development advisory services.
What is Avania's vision?
Avania aims to be a trusted global partner in the evolution of medical technology, advancing it from innovation to commercialization.
How does Charlene Dark plan to contribute to Avania?
Charlene Dark intends to foster innovation and align operational strategies to meet the current challenges in the MedTech industry while ensuring long-term success for Avania.
